SIRT1 deletion in hepatocytes impaired the activity of PPARα, resulting in development of hepatic steatosis, whereas SIRT1 hepatic overexpression suppressed the expression of gluconeogenic genes and attenuated obesity-induced ERS [16, 17]. This evidence concerns the gene SIRT1 and fatty liver disease.